Purification, crystallization and preliminary X-ray analysis of the aspartate aminotransferase of Plasmodium falciparum.
Aspartate aminotransferases (EC 2.6.1.1) catalyse the conversion of aspartate and alpha-ketoglutarate to oxaloacetate and glutamate in a reversible manner. Thus, the aspartate aminotransferase of Plasmodium falciparum (PfAspAT) plays a central role in the transamination of amino acids. Recent findings suggest that PfAspAT may also play a pivotal role in energy metabolism and the de novo biosynthesis of pyrimidines. While therapeutics based upon the inhibition of other proteins in these pathways are already used in the treatment of malaria, the advent of multidrug-resistant strains has limited their efficacy. The presence of PfAspAT in these pathways may offer additional opportunities for the development of novel therapeutics. In order to gain a deeper understanding of the function and role of PfAspAT, it has been expressed and purified to homogeneity. The successful crystallization of PfAspAT, the collection of a 2.8 A diffraction data set and initial attempts to solve the structure using molecular replacement are reported.
Jain
Rishabh
R
European Molecular Biology Laboratory Hamburg Outstation, Notkestrasse 85, D-22603 Hamburg, Germany.
Jordanova
Rositsa
R
Müller
Ingrid B
IB
Wrenger
Carsten
C
Groves
Matthew R
MR
D001219:Aspartate Aminotransferases / Q000737:chemistry* / Q000302:isolation & purification; D003460:Crystallization; D018360:Crystallography, X-Ray; D010963:Plasmodium falciparum / Q000201:enzymology*
D001219:Aspartate Aminotransferases
Lancet Infect Dis. 2002 Sep;2(9):564-73
12206972
Biochemistry. 2007 Sep 18;46(37):10517-27
17713924
J Bacteriol. 2001 Aug;183(15):4421-34
11443076
J Biochem. 1996 Jan;119(1):135-44
8907187
N Engl J Med. 2009 Jul 30;361(5):455-67
19641202
J Bacteriol. 1999 Mar;181(6):1739-47
10074065
Lancet Infect Dis. 2002 Apr;2(4):209-18
11937421
Antimicrob Agents Chemother. 2000 Sep;44(9):2540-2
10952611
Annu Rev Pharmacol Toxicol. 1995;35:55-91
7598507
Antimicrob Agents Chemother. 1995 Nov;39(11):2511-5
8585735
Eur J Biochem. 1993 Jun 1;214(2):549-61
8513804
Acta Crystallogr D Biol Crystallogr. 2007 Apr;63(Pt 4):526-35
17372358
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
16369096
Nature. 1970 Aug 15;227(5259):680-5
5432063
J Biol Chem. 2005 Mar 11;280(10):9547-54
15576366
Acta Crystallogr D Biol Crystallogr. 2006 Dec;62(Pt 12):1446-52
17139079
FEMS Microbiol Lett. 1998 Aug 15;165(2):305-12
9742703
N Engl J Med. 2009 Jul 30;361(5):540-1
19641219
J Indian Med Assoc. 2008 Oct;106(10):678-81, 683
19552104
Eur J Biochem. 1990 Apr 20;189(1):1-23
2185018
Pharmacol Ther. 2001 Feb;89(2):207-19
11316521
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
10592235
J Antimicrob Chemother. 2003 Aug;52(2):290-3
12837742
Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):125-32
18094476
Protein Sci. 2003 Sep;12(9):1865-71
12930986
Antimicrob Agents Chemother. 2005 Jul;49(7):2857-64
15980361
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):48-57
16369093
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Methods Mol Biol. 2008;426:299-318
18542872
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):58-64
16369094
Am J Trop Med Hyg. 2009 Aug;81(2):338-42
19635895
J Mol Biol. 1968 Apr 28;33(2):491-7
5700707
Mol Biochem Parasitol. 2008 Jul;160(1):1-7
18455248
J Biol Chem. 1998 Feb 27;273(9):4982-9
9478945
Acta Crystallogr D Biol Crystallogr. 2003 Jul;59(Pt 7):1145-53
12832757